PlumX Metrics
Embed PlumX Metrics

Optimizing the management of metastatic colorectal cancer

Critical Reviews in Oncology/Hematology, ISSN: 1040-8428, Vol: 75, Issue: 1, Page: 15-26
2010
  • 4
    Citations
  • 0
    Usage
  • 19
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Review Description

The prognosis of patients with metastatic colorectal cancer has significantly improved in the last few years, with the introduction into the clinical practice of new cytotoxic treatments, the availability of non-cross resistant agents after the front-line treatment failure, and the combination of targeted agents (i.e., the inhibitors of the epidermal growth factor and vascular endothelial growth factor pathways) with conventional drugs. All these options must be incorporated into a complex strategy of management, in which a customized management according to the disease status, with an intensified induction approach followed by maintenance (and reinduction), should be investigated.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know